MIR635: A Potential Cancer Target and Biomarker (G693220)
MIR635: A Potential Cancer Target and Biomarker
MIR635 (hsa-mir-635) is a protein that is expressed in various tissues of the body, including the brain, heart, and peripheral tissues. Its primary function is to regulate the blood flow to the body's tissues, which is essential for maintaining proper cellular function and growth. MIR635 is a member of the Integrin alpha-2 (Ia2) family, which is known for its role in cell-cell and cell-tissue adhesion, as well as its involvement in the regulation of cell cycle progression.
MIR635 has been identified as a potential drug target due to its unique biology and the disease it is associated with. One of the most significant findings related to MIR635 is its involvement in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancer. MIR635 has also been shown to promote the growth and survival of cancer cells, which suggests that it may be a useful biomarker or drug target in these diseases.
In addition to its potential cancer-promoting properties, MIR635 has also been shown to play a role in the regulation of blood flow and oxygenation in the body's tissues. This is important for maintaining the health and function of tissues, as adequate blood flow is essential for the delivery of oxygen and nutrients and the removal of waste products.
MIR635 has been shown to regulate the expression of genes involved in the formation of blood vessels, as well as the growth and maintenance of blood vessels themselves. This suggests that MIR635 may be a useful target for drugs that are designed to improve blood flow and oxygenation in the body's tissues.
Another potential mechanism by which MIR635 may be involved in the development and progression of cancer is its role in the regulation of cell signaling pathways. MIR635 has been shown to interact with various signaling pathways, including the TGF-beta pathway and the PI3K/Akt signaling pathway. These pathways are involved in the regulation of cell growth, differentiation, and survival, and are often disrupted in cancer cells. By targeting MIR635 with drugs that can restore these signaling pathways, researchers may be able to develop new treatments for cancer.
MIR635 is also of interest as a potential biomarker for monitoring the effectiveness of cancer treatments. By measuring the levels of MIR635 in cancer cells and cancer tissues, researchers can determine the effectiveness of different treatments and identify potential areas for improvement. This information could be valuable for guiding future research in cancer treatment and for developing new, more effective therapies.
In conclusion, MIR635 is a protein that has significant potential as a drug target or biomarker for the development and progression of cancer. Its involvement in the regulation of blood flow and oxygenation, as well as its role in the regulation of cell signaling pathways, make it an attractive target for researchers looking for new treatments for cancer. Further studies are needed to fully understand the biology and potential clinical applications of MIR635, but its potential as a drug target or biomarker is clear.
Protein Name: MicroRNA 635
The "MIR635 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR635 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR636 | MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754
